NCT06623474View on ClinicalTrials.gov

Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

June 30, 2032

Study Completion Date

July 1, 2032

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

diagnosed by traditional diagnostic markers（such as AFP or CT etc.）

A prospective observational cohort study to explore the advantages of lipid metabolites as diagnostic markers for hepatocellular carcinoma compared to traditional diagnostic markers for hepatocellular carcinoma (e.g., AFP, enhanced CT, etc.).

Trial Locations (1)

510515

RECRUITING

Nanfang Hospital, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER